Rights and responsibilities of pharmacy business establishments in declaration of drug prices from December 11, 2023 in Vietnam

Rights and responsibilities of pharmacy business establishments in declaration of drug prices from December 11, 2023 in Vietnam

Rights and responsibilities of pharmacy business establishments in implementing regulations on declaration and redeclaration of drug prices specified in Article 133 of Decree 54/2017/ND-CP are amendedd as follows:

(1) Pharmacy business establishments have the right to:

Purchase, sell drugs at declared, redeclared price from the date on which manufacturing facilities, processing service buyers, importing facilities submit adequate declarations or redeclarations to competent authority as per the law. Purchase, sell drugs at a lower price while declaring price reduction if importing facilities, manufacturing facilities, or processing service buyers lower declared price relative to previous declarations.

(2) Pharmacy business establishments have the responsibility to:

- adequately comply with regulations on declaration and redeclaration of drug price, notify price in accordance with regulations and this Decree; assume total legal responsibility for accuracy and veracity of drug price declarations, redeclarations; produce reports on declared, redeclared price at request of drug pricing authorities; comply with examination and inspection of competent authority (if any);

- not sell drugs in bulk or retail drugs at a price higher than declared or redeclared price which has been declared, redeclared by manufacturing facilities, processing service buyers, importing facilities;

- if competent authority request pharmacy business establishments to produce reports on drug prices declared and redeclared by the pharmacy business establishments, the pharmacy business establishments shall respond in form of reports on declared prices conforming to price level of similar products on the market or fluctuations of price factors within 30 days from the date on which request of competent authority is issued or adjust declared, redeclared prices in accordance with feedback of drug pricing authority. If pharmacy business establishments fail to respond in writing within the time limit above, submitted declarations and redeclarations shall be voided;

- comply with actions taken against drug price declaration in accordance with regulations on administrative penalties in prices, fees, charges, and invoices.

Decree 88/2023/ND-CP takes effect on December 11, 2023.

>> CLICK HERE TO READ THIS ARTICLE IN VIETNAMESE